Innova Captab Limited (INNOVACAP) - Total Liabilities
Based on the latest financial reports, Innova Captab Limited (INNOVACAP) has total liabilities worth Rs7.47 Billion INR (≈ $80.74 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Innova Captab Limited - Total Liabilities Trend (2018–2026)
This chart illustrates how Innova Captab Limited's total liabilities have evolved over time, based on quarterly financial data. See Innova Captab Limited working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Innova Captab Limited Competitors by Total Liabilities
The table below lists competitors of Innova Captab Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ningbo Fangzheng Automobile Mould Co.Ltd.
SHE:300998
|
China | CN¥1.20 Billion |
|
Ares Acquisition Corporation II
NYSE:AACT
|
USA | $27.00 Million |
|
Actron Technology
TWO:8255
|
Taiwan | NT$5.77 Billion |
|
Cheng Uei Precision Industry Co Ltd
TW:2392
|
Taiwan | NT$95.67 Billion |
|
Red River Bancshares Inc
NASDAQ:RRBI
|
USA | $2.97 Billion |
|
Tian Jin Global Magnetic Card Co Ltd
SHG:600800
|
China | CN¥3.64 Billion |
|
Core Laboratories NV
NYSE:CLB
|
USA | $312.58 Million |
|
Beijing Jingpin Tezhuang Technology Co. Ltd. A
SHG:688084
|
China | CN¥254.10 Million |
Liability Composition Analysis (2018–2026)
This chart breaks down Innova Captab Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see INNOVACAP market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.87 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.68 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Innova Captab Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Innova Captab Limited (2018–2026)
The table below shows the annual total liabilities of Innova Captab Limited from 2018 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs7.47 Billion ≈ $80.74 Million |
+20.23% |
| 2025-03-31 | Rs6.21 Billion ≈ $67.16 Million |
+26.74% |
| 2024-03-31 | Rs4.90 Billion ≈ $52.99 Million |
-29.31% |
| 2023-03-31 | Rs6.93 Billion ≈ $74.96 Million |
+88.93% |
| 2022-03-31 | Rs3.67 Billion ≈ $39.68 Million |
+63.20% |
| 2021-03-31 | Rs2.25 Billion ≈ $24.31 Million |
+131359.06% |
| 2020-03-31 | Rs1.71 Million ≈ $18.49K |
-99.94% |
| 2019-03-31 | Rs2.98 Billion ≈ $32.23 Million |
+113.03% |
| 2018-03-31 | Rs1.40 Billion ≈ $15.13 Million |
-- |
About Innova Captab Limited
Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also offers various generic formulation products, including cephalosporins, proton pump inhib… Read more